Professional Documents
Culture Documents
Downloaded from www.nejm.org on May 9, 2010 . For personal use only. No other uses without permission.
Copyright © 2010 Massachusetts Medical Society. All rights reserved.
PERS PE C T IV E Thinking Outside the Pillbox
Downloaded from www.nejm.org on May 9, 2010 . For personal use only. No other uses without permission.
Copyright © 2010 Massachusetts Medical Society. All rights reserved.
PE R S PE C T IV E Thinking Outside the Pillbox
organizations, and care transition prescribing and in follow-up con- existing movements toward de-
teams. In the short run, efforts tacts with patients. ployment of HIT, improved co-
aimed at increasing adherence to Once the right patients are ordination of care, and payment
medication regimens will require targeted, there is still a lot to reform together create a desire
funds to be allocated up front. learn about tailoring adherence and an infrastructure for improv-
Over time, there should be sav- interventions to individual pa- ing health outcomes through im-
ings. Thus, the structure of reim- tients. Although we know about proved adherence. Now we just
bursement must create an induce- many common features of ad- need to get moving.
ment for investment (typically by herence programs, it is more Disclosure forms provided by the au-
providers) that is financed by the difficult to determine the best thors are available with the full text of this
article at NEJM.org.
groups that will save (usually in- possible combination of such fea-
surers). tures for any given person. New From Harvard University (D.M.C.) and the
New England Healthcare Institute (W.E.) —
Finally, there needs to be investments in research, includ- both in Cambridge, MA.
greater use of proven screening ing efforts associated with the
This article (10.1056/NEJMp1002305) was
and assessment tools to identify government’s expanded program published on April 7, 2010, at NEJM.org.
and target the patients who are of comparative-effectiveness re-
at the greatest risk for nonad- search, could dramatically en- 1. Osterberg L, Blaschke T. Adherence to
medication. N Engl J Med 2005;353:487-97.
herence. Treatment guidelines for hance the evidence base for ef- 2. Cutler DM, Long G, Berndt ER, et al. The
chronic conditions, for instance, fective adherence interventions. value of antihypertensive drugs: a perspec
should recommend screening for The bottom line is this: We’ve tive on medical innovation. Health Aff (Mill
wood) 2007;26:97-110.
depression, which can be an in- known for some time that im- 3. Doshi JA, Zhu J, Lee BY, Kimmel S, Volpp
dicator of poor adherence. In proved adherence can lead to im- KG. Impact of a prescription copayment in
addition, assessment tools can provements in health outcomes crease on lipid-lowering medication adher
ence in veterans. Circulation 2009;119:390-7.
broadly predict a patient’s pro- and reductions in health care 4. Mosen DM, Schmittdiel J, Hibbard J, So
clivity to adhere to treatment,4 spending. What we haven’t known bel D, Remmers C, Bellows J. Is patient acti
which is valuable information for is where to start. With the new vation associated with outcomes of care for
adults with chronic conditions? J Ambul Care
providers to use in encouraging federal health care reform law Manage 2007;30:20-9.
adherence both at the point of moving into implementation, the Copyright © 2010 Massachusetts Medical Society.
Downloaded from www.nejm.org on May 9, 2010 . For personal use only. No other uses without permission.
Copyright © 2010 Massachusetts Medical Society. All rights reserved.